Dement Neurocogn Disord.  2018 Jun;17(2):66-70. 10.12779/dnd.2018.17.2.66.

Early Onset Alzheimer's Disease Presenting as Logopenic Primary Progressive Aphasia

Affiliations
  • 1Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Neurology, Seoul National University College of Medicine and Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Korea. neuroksy@snu.ac.kr
  • 3Department of Neurology, Wonkwang University School of Medicine and Regional Cardiocerebrovascular Center, Iksan, Korea.

Abstract

No abstract available.


MeSH Terms

Alzheimer Disease*
Aphasia, Primary Progressive*

Figure

  • Fig. 1 Brain MRI image of the patient taken in October 2015. (A) Axial FLAIR image, (B) axial T1-weighted image, and (C) coronal-oblique T1-weighted image. MRI: magnetic resonance imaging, FLAIR: fluid-attenuated inversion recovery.

  • Fig. 2 FDG-PET image of the patient, taken in December 2015. (A, B) Axial FDG-PET images each in different planes. FDG: fluorodeoxyglucose, PET: positron emission tomography.

  • Fig. 3 Amyloid-PET image of the patient taken in December 2015, showing extended uptake to the cortical gray matter. (A) Axial image and (B) coronal image. PET: positron emission tomography.


Reference

1. Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982; 11:592–598.
Article
2. Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology. 2008; 71:1227–1234.
Article
3. Mesulam M, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008; 63:709–719.
Article
4. Kang YW, Jang SM, Na DL. Seoul Neuropsychological Screening Battery-II. Seoul: Human Brain Research & Consulting Co.;2012.
5. Skillbäck T, Farahmand BY, Rosén C, Mattsson N, Nägga K, Kilander L, et al. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia. Brain. 2015; 138:2716–2731.
Article
6. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006; 5:228–234.
Article
7. Matías-Guiu JA, Cabrera-Martín MN, Moreno-Ramos T, Valles-Salgado M, Fernandez-Matarrubia M, Carreras JL, et al. Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes. J Neurol. 2015; 262:1463–1472.
Article
8. Teichmann M, Kas A, Boutet C, Ferrieux S, Nogues M, Samri D, et al. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. Brain. 2013; 136:3474–3488.
Article
9. Henry ML, Gorno-Tempini ML. The logopenic variant of primary progressive aphasia. Curr Opin Neurol. 2010; 23:633–637.
Article
10. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76:1006–1014.
Article
Full Text Links
  • DND
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr